Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin
Language English Country Sweden Media print
Document type Journal Article
PubMed
30531705
PII: NEL390418A08
Knihovny.cz E-resources
- MeSH
- Behavior, Animal drug effects MeSH
- Brain Edema physiopathology MeSH
- Erythropoietin pharmacology MeSH
- Water Intoxication physiopathology MeSH
- Rats MeSH
- Locomotion drug effects MeSH
- Neuroprotective Agents pharmacology MeSH
- Motor Activity drug effects MeSH
- Rats, Wistar MeSH
- Recombinant Proteins pharmacology MeSH
- Age Factors MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- EPO protein, human MeSH Browser
- Erythropoietin MeSH
- Neuroprotective Agents MeSH
- Recombinant Proteins MeSH
OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.) administration of rhEPO, followed by induction of cellular brain edema (CE). Induced changes in the spontaneous horizontal locomotor activity was studied by open field test (OFT). METHODS: CE was induced by water intoxication (WI) using standard method of fractional hyperhydration accompanied with desmopressin administration. Using the accepted method of OFT average time spent in locomotion (s) was determined. 48 young rats at the age of 25, and 35 days were divided into three groups - controls, rats after WI (OFT followed after 44 hours), and rats administered with rhEPO prior to application WI (OFT after 48 hours). RESULTS: In 35-day-old rats rhEPO administration increased the spontaneous locomotor activity, previously decreased by cellular edema. In 25-day-old rats, rhEPO administration prior to the induced CE, decreased spontaneous locomotor activity. CONCLUSION: Presented results demonstrate the neuroprotective capacity of rhEPO, manifested by elimination of the suppressive influence of CE on the locomotion in 35-day-old rats. In 25-day-old rats the neuroprotective effect was not present. These results confirmed that the 10 day interval in the development may represent a different stage of brain maturation in the relation to the neuroprotective effect of rhEPO.